Evolution of hybrid interventions for congenital heart disease

Hitesh Agrawal, Wail Alkashkari, Damien Kenny

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Introduction: Surgical and transcatheter interventions have seen a tremendous evolution in last three decades. Hybrid technology combines the achievements of both disciplines to bring substantial hemodynamic benefit to patients with congenital heart disease (CHD) in a minimally invasive manner. This collaboration between surgeons and interventionalists will continue to grow as the technology evolves to meet the demands of CHD patients, potentially avoiding cardiopulmonary bypass and vascular access complications as well as optimizing immediate technical outcomes with exit angiography. Areas covered: This review covers application of such technology to initial palliation of infants with hypoplastic left heart syndrome, ventricular septal defect closure, pulmonary atresia with intact ventricular septum, pulmonary valve replacement, intra-operative pulmonary artery stenting and vascular cut-down in small neonates. Expert commentary: Careful planning and investment in infrastructure is necessary to optimize outcomes, however patients can benefit tremendously from integration of this approach into clinical practice.

Original languageEnglish (US)
Pages (from-to)257-266
Number of pages10
JournalExpert Review of Cardiovascular Therapy
Volume15
Issue number4
DOIs
StatePublished - Apr 3 2017
Externally publishedYes

Fingerprint

Heart Diseases
Technology
Blood Vessels
Hypoplastic Left Heart Syndrome
Pulmonary Valve
Ventricular Heart Septal Defects
Cardiopulmonary Bypass
Pulmonary Artery
Angiography
Hemodynamics
Newborn Infant
Pulmonary Atresia with Intact Ventricular Septum
Surgeons

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Evolution of hybrid interventions for congenital heart disease. / Agrawal, Hitesh; Alkashkari, Wail; Kenny, Damien.

In: Expert Review of Cardiovascular Therapy, Vol. 15, No. 4, 03.04.2017, p. 257-266.

Research output: Contribution to journalReview article

Agrawal, Hitesh ; Alkashkari, Wail ; Kenny, Damien. / Evolution of hybrid interventions for congenital heart disease. In: Expert Review of Cardiovascular Therapy. 2017 ; Vol. 15, No. 4. pp. 257-266.
@article{668ecbe66bba49369912222e474f3b65,
title = "Evolution of hybrid interventions for congenital heart disease",
abstract = "Introduction: Surgical and transcatheter interventions have seen a tremendous evolution in last three decades. Hybrid technology combines the achievements of both disciplines to bring substantial hemodynamic benefit to patients with congenital heart disease (CHD) in a minimally invasive manner. This collaboration between surgeons and interventionalists will continue to grow as the technology evolves to meet the demands of CHD patients, potentially avoiding cardiopulmonary bypass and vascular access complications as well as optimizing immediate technical outcomes with exit angiography. Areas covered: This review covers application of such technology to initial palliation of infants with hypoplastic left heart syndrome, ventricular septal defect closure, pulmonary atresia with intact ventricular septum, pulmonary valve replacement, intra-operative pulmonary artery stenting and vascular cut-down in small neonates. Expert commentary: Careful planning and investment in infrastructure is necessary to optimize outcomes, however patients can benefit tremendously from integration of this approach into clinical practice.",
author = "Hitesh Agrawal and Wail Alkashkari and Damien Kenny",
year = "2017",
month = "4",
day = "3",
doi = "10.1080/14779072.2017.1307733",
language = "English (US)",
volume = "15",
pages = "257--266",
journal = "Expert Review of Cardiovascular Therapy",
issn = "1477-9072",
publisher = "Expert Reviews Ltd.",
number = "4",

}

TY - JOUR

T1 - Evolution of hybrid interventions for congenital heart disease

AU - Agrawal, Hitesh

AU - Alkashkari, Wail

AU - Kenny, Damien

PY - 2017/4/3

Y1 - 2017/4/3

N2 - Introduction: Surgical and transcatheter interventions have seen a tremendous evolution in last three decades. Hybrid technology combines the achievements of both disciplines to bring substantial hemodynamic benefit to patients with congenital heart disease (CHD) in a minimally invasive manner. This collaboration between surgeons and interventionalists will continue to grow as the technology evolves to meet the demands of CHD patients, potentially avoiding cardiopulmonary bypass and vascular access complications as well as optimizing immediate technical outcomes with exit angiography. Areas covered: This review covers application of such technology to initial palliation of infants with hypoplastic left heart syndrome, ventricular septal defect closure, pulmonary atresia with intact ventricular septum, pulmonary valve replacement, intra-operative pulmonary artery stenting and vascular cut-down in small neonates. Expert commentary: Careful planning and investment in infrastructure is necessary to optimize outcomes, however patients can benefit tremendously from integration of this approach into clinical practice.

AB - Introduction: Surgical and transcatheter interventions have seen a tremendous evolution in last three decades. Hybrid technology combines the achievements of both disciplines to bring substantial hemodynamic benefit to patients with congenital heart disease (CHD) in a minimally invasive manner. This collaboration between surgeons and interventionalists will continue to grow as the technology evolves to meet the demands of CHD patients, potentially avoiding cardiopulmonary bypass and vascular access complications as well as optimizing immediate technical outcomes with exit angiography. Areas covered: This review covers application of such technology to initial palliation of infants with hypoplastic left heart syndrome, ventricular septal defect closure, pulmonary atresia with intact ventricular septum, pulmonary valve replacement, intra-operative pulmonary artery stenting and vascular cut-down in small neonates. Expert commentary: Careful planning and investment in infrastructure is necessary to optimize outcomes, however patients can benefit tremendously from integration of this approach into clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=85016400869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016400869&partnerID=8YFLogxK

U2 - 10.1080/14779072.2017.1307733

DO - 10.1080/14779072.2017.1307733

M3 - Review article

VL - 15

SP - 257

EP - 266

JO - Expert Review of Cardiovascular Therapy

JF - Expert Review of Cardiovascular Therapy

SN - 1477-9072

IS - 4

ER -